Fig. 6From: Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysisSensitivity analysis using the leave-one-out test for overall survival (OS) and progression-free survival (PFS). a OS; b PFSBack to article page